Treatment for Infection Secondary to Vaginal Rectal Fistula
Immediate surgical drainage of any associated abscess is the essential first step, followed by placement of a non-cutting seton and adjunctive antibiotic therapy—antibiotics alone without surgical drainage will fail. 1, 2
Initial Management: Control the Sepsis
The priority is surgical intervention to drain the infection:
- Perform urgent surgical drainage of the intersphincteric or perirectal abscess under anesthesia to control sepsis before any other treatment 1, 2
- Place a loose, non-cutting seton during the initial drainage procedure to maintain ongoing drainage and prevent recurrent abscess formation 1, 3
- Avoid probing for fistula tracts during the acute infection phase, as this risks iatrogenic complications and sphincter injury 4
The World Society of Emergency Surgery emphasizes that attempting definitive fistula repair during active infection leads to treatment failure and complications 1, 2
Antibiotic Therapy: Adjunctive, Not Primary
Antibiotics are necessary but insufficient as monotherapy:
- Start broad-spectrum antibiotics covering gram-positive, gram-negative, and anaerobic bacteria after surgical drainage 2, 5
- Metronidazole is FDA-approved for anaerobic bacterial infections including gynecologic infections and intra-abdominal abscesses, which are the typical pathogens in rectovaginal fistulas 5
- Continue antibiotics for 1-2 weeks as adjunctive therapy, not as primary treatment 2
- Obtain cultures of drained pus in high-risk patients (immunocompromised, diabetes, recurrent infections) or those with risk factors for multidrug-resistant organisms 4
A critical pitfall: relying on antibiotics without adequate surgical drainage has high failure rates and promotes antibiotic resistance 2, 6
Subsequent Management After Infection Control
Once sepsis is controlled and inflammation subsides:
- Avoid definitive surgical repair until the infection has completely resolved and inflammation has subsided for several weeks to months 1, 7
- Consider diverting colostomy or ileostomy for severe symptoms, large fistulas, or to allow healing in complex cases 7, 6
- For Crohn's disease-related fistulas, consider anti-TNF therapy (infliximab) after adequate drainage and sepsis control, as this is FDA-approved and proven effective in placebo-controlled trials 4, 2
- Immunosuppressive agents (azathioprine, 6-mercaptopurine) may help maintain fistula closure but are slow-acting and should not be started until sepsis is completely resolved 4, 1
Definitive Repair Options (After Infection Resolution)
The approach depends on fistula complexity and location:
- For simple, low fistulas: transanal advancement flap or local repair techniques have success rates of 75-100% 7, 8
- For complex or recurrent fistulas: interposition of healthy, well-vascularized tissue (Martius flap using labial fat pad) improves outcomes 7, 6
- For high rectovaginal fistulas: transabdominal approaches may be necessary 7, 9
Critical Pitfalls to Avoid
- Never delay surgical drainage while continuing antibiotics alone—this leads to treatment failure and spread of infection 1, 2
- Never attempt definitive fistula repair during active infection or inflammation, as this dramatically increases failure rates 1, 7
- Never start immunosuppressive therapy before complete surgical drainage of sepsis, as this risks serious infectious complications 1
- Never perform fistulotomy for high or complex fistulas involving significant sphincter muscle, as this causes incontinence 4, 3
Monitoring and Follow-up
- Assess clinical response by monitoring decreased drainage and symptom improvement 3
- Consider MRI or endosonography to evaluate fistula tract inflammation after initial treatment 3
- Long-term follow-up for at least 12 months is essential, as recurrence rates are significant (25-33% in some series) 2, 3, 6
budget:token_budget200000